Literature DB >> 16390735

Frailty and the aging male.

J E Morley1, M J Kim, M T Haren, R Kevorkian, W A Banks.   

Abstract

Frailty occurs in aging males for a variety of reasons. It is less common in males than females. Diseases which are particularly associated with frailty are diabetes mellitus, atherosclerosis, anemia and chronic obstructive pulmonary disease. Insulin resistance syndrome plays a pathogenetic role in the "fat-frail" syndrome. Sarcopenia occurs predominantly because of hormone deficiency and cytokine excess. Pain and anorexia are also associated with frailty. Stem cell research represents a potential promise for the treatment of frailty.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16390735     DOI: 10.1080/13685530500277232

Source DB:  PubMed          Journal:  Aging Male        ISSN: 1368-5538            Impact factor:   5.892


  22 in total

Review 1.  Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy.

Authors:  Thomas W Buford; Stephen D Anton; Andrew R Judge; Emanuele Marzetti; Stephanie E Wohlgemuth; Christy S Carter; Christiaan Leeuwenburgh; Marco Pahor; Todd M Manini
Journal:  Ageing Res Rev       Date:  2010-05-14       Impact factor: 10.895

Review 2.  Sarcopenia: diagnosis and treatment.

Authors:  J E Morley
Journal:  J Nutr Health Aging       Date:  2008 Aug-Sep       Impact factor: 4.075

Review 3.  Muscle wasting in heart failure : The role of nutrition.

Authors:  Masakazu Saitoh; Marcelo Rodrigues Dos Santos; Stephan von Haehling
Journal:  Wien Klin Wochenschr       Date:  2016-10-19       Impact factor: 1.704

4.  The relationship between body weight, frailty, and the disablement process.

Authors:  Mary Elizabeth Bowen
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2012-09       Impact factor: 4.077

Review 5.  Testosterone replacement therapy for late-onset hypogonadism: current trends in Korea.

Authors:  Young Hwii Ko; Je Jong Kim
Journal:  Asian J Androl       Date:  2011-05-16       Impact factor: 3.285

6.  Sarcopenia: designing phase IIB trials.

Authors:  Wm C Chumlea; M Cesari; W J Evans; L Ferrucci; R A Fielding; M Pahor; S Studenski; B Vellas
Journal:  J Nutr Health Aging       Date:  2011-06       Impact factor: 4.075

Review 7.  Muscle wasting and cachexia in heart failure: mechanisms and therapies.

Authors:  Stephan von Haehling; Nicole Ebner; Marcelo R Dos Santos; Jochen Springer; Stefan D Anker
Journal:  Nat Rev Cardiol       Date:  2017-04-24       Impact factor: 32.419

8.  An overview of sarcopenia: facts and numbers on prevalence and clinical impact.

Authors:  Stephan von Haehling; John E Morley; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2010-12-17       Impact factor: 12.910

Review 9.  Frailty and safety: the example of diabetes.

Authors:  Angela M Abbatecola; Fabiola Olivieri; Andrea Corsonello; Felice Strollo; Alessia Fumagalli; Fabrizia Lattanzio
Journal:  Drug Saf       Date:  2012-01       Impact factor: 5.606

10.  The benefits and risks of testosterone replacement therapy: a review.

Authors:  Nazem Bassil; Saad Alkaade; John E Morley
Journal:  Ther Clin Risk Manag       Date:  2009-06-22       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.